In contrast, combined genomic, transcriptomic, and clinical data analysis unveils a higher mortality in patients with glioma with downregulation of CLOCK. Changes in expression of the core clock proteins furthermore influence the internal timekeeping. The gene discussed is CLOCK; the disease is central nervous system cancer.